Akèy › Glomeruloskleroz fokal segmantè › Texas › Dallas
Etid klinik pou Glomeruloskleroz fokal segmantè nan Dallas, TX
4 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Ap rekriteFaz 2
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Ap rekriteFaz 3
- Advanced Dallas Hospital and Clinics, Dallas
- Nephrotex Research Group, Dallas
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Ap rekriteFaz 2
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
Nephrotic Syndrome Study Network
Ap rekriteEtid obsèvasyon
- University of Texas-Southwestern, Dallas
Etid Glomeruloskleroz fokal segmantè nan lòt vil
- Philadelphia, PA9 etid
- Durham, NC8 etid
- New York City, NY7 etid
- Ann Arbor, MI6 etid
- Queens, NY6 etid
- Miami, FL6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Atlanta, GA5 etid
- Cleveland, OH4 etid
- Chicago, IL4 etid
- Kansas City, MO4 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.